News articles about St Jude Medical (NYSE:STJ) have trended positive recently, according to InfoTrie Sentiment. InfoTrie rates the sentiment of press coverage by reviewing more than 6,000 blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. St Jude Medical earned a news impact score of 2.83 on their scale. InfoTrie also gave news stories about the medical technology company an news buzz score of 10 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock’s share price in the near term.
NYSE STJ opened at $80.82 on Monday. St Jude Medical has a one year low of $48.83 and a one year high of $84.00.
About St Jude Medical
St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.
Recommended Story: How to interpret a stock’s beta number
Receive News & Ratings for St Jude Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St Jude Medical and related companies with MarketBeat.com's FREE daily email newsletter.